Data search


search
Exact
Search

Results for MligTC455_41020

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_41020 603 12.57 Mlig455_032493

Neo: -

Age: Up-Down-Down

SGSM1 Mlig455_032493 {REF} {Length: 5426} {Pfam: Rab-binding domain (RBD) [PF12068.10, score=113.2]; Rab-GTPase-TBC domain [PF00566.20, score=99.4]; RUN domain [PF02759.21, score=68.0]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [Score=369, Expect=4e-109]} {Mouse: ENSMUSG00000038351, Sgsm2, small G protein signaling modulator 2, [Score=464, Expect=3e-145]} {Dmel: FBgn0052506, CG32506, [Score=283, Expect=1e-78]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=214, Expect=3e-58]} {Smed: dd_Smed_v6_3307_0_1, dd_Smed_v6_3307_0_1, [Score=394, Expect=7e-119]} {RNA1509_23023} {RNA1310_13249.1} {RNA815_3765}

Cumulative graph for MligTC455_41020

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -6.326 3.931 0.08689 0.63793
RegionR2 1.502 3.931 0.02903 0.19245
RegionR3 0.446 3.931 0.59719 1.00000
RegionR4 1.056 3.931 0.18323 0.45478
RegionR5 0.041 3.931 0.83186 1.00000
RegionR6 0.614 3.931 0.46551 1.00000
RegionR7 1.306 3.931 0.09466 0.58857
RegionR8 1.361 3.931 0.14456 0.69355

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 6.723 3.931 0.08207 0.78003
RegenerationR2 -0.365 3.931 0.29574 0.73818
RegenerationR3 0.2 3.931 0.64538 0.92682
RegenerationR4 -0.442 3.931 0.31523 0.75476
RegenerationR5 0.122 3.931 0.77003 0.97898
RegenerationR6 0.317 3.931 0.46904 0.78388
RegenerationBL 0.051 3.931 0.91662 1.00000
RegenerationTP -0.397 3.931 0.46659 0.87849


Genes with expression patterns similar to MligTC455_41020

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_41020 603 12.57 Mlig455_032493

Neo: -

Age: Up-Down-Down

SGSM1 6 1.000 1.000 1.000 1.000 1.000 1.000 Mlig455_032493 {REF} {Length: 5426} {Pfam: Rab-binding domain (RBD) [PF12068.10, score=113.2]; Rab-GTPase-TBC domain [PF00566.20, score=99.4]; RUN domain [PF02759.21, score=68.0]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [Score=369, Expect=4e-109]} {Mouse: ENSMUSG00000038351, Sgsm2, small G protein signaling modulator 2, [Score=464, Expect=3e-145]} {Dmel: FBgn0052506, CG32506, [Score=283, Expect=1e-78]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=214, Expect=3e-58]} {Smed: dd_Smed_v6_3307_0_1, dd_Smed_v6_3307_0_1, [Score=394, Expect=7e-119]} {RNA1509_23023} {RNA1310_13249.1} {RNA815_3765}
2. MligTC455_33675 223 4.64 Mlig455_053356

Neo: -

Age: -

DMD 0.968 - - - 0.968 - - Mlig455_053356 {REF} {Length: 7940} {Pfam: EF-hand [PF09069.13, score=97.7]; EF hand [PF09068.13, score=83.1]; Zinc finger, ZZ type [PF00569.19, score=41.3]} {Human: ENSG00000198947, DMD, dystrophin, [Score=382, Expect=8e-107]} {Mouse: ENSMUSG00000045103, Dmd, dystrophin, muscular dystrophy, [Score=382, Expect=9e-107]} {Dmel: FBgn0260003, Dys, Dystrophin, [Score=343, Expect=1e-96]} {Celegans: WBGene00001131, dys-1, Dystrophin-1, [Score=285, Expect=6e-77]} {Smed: dd_Smed_v6_5325_0_3, dd_Smed_v6_5325_0_3, [Score=226, Expect=4e-59]} {RNA1509_19045} {RNA1310_18748, RNA1509_19045} {RNA1509_19045, RNA815_16702}
3. MligTC455_42699 1094 22.78 Mlig455_014358

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.568

Region-enriched R2: 1.315/0.02072

YWHAE 0.963 - - - 0.963 - - Mlig455_014358 {REF} {Length: 1925} {Pfam: 14-3-3 protein [PF00244.22, score=229.3]} {Human: ENSG00000274474, YWHAE, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon, [Score=275, Expect=3e-93]; ENSG00000108953, YWHAE, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon, [Score=275, Expect=3e-93]} {Mouse: ENSMUSG00000020849, Ywhae, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide, [Score=275, Expect=2e-93]} {Dmel: FBgn0020238, 14-3-3epsilon, [Score=260, Expect=7e-88]} {Celegans: WBGene00001502, ftt-2, 14-3-3-like protein 2, [Score=208, Expect=1e-67]} {Smed: dd_Smed_v6_1702_0_1, dd_Smed_v6_1702_0_1, [Score=248, Expect=3e-83]} {RNA1509_43335} {RNA1310_15023.1} {RNA815_5579}
4. MligTC455_53842 1222 25.46 Mlig455_023890

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.345

Region-enriched R2: 1.546/0.01667

0.963 - - 0.963 - - - Mlig455_023890 {REF} {Length: 1336} {RNA1509_15580} {RNA1310_22487.1} {RNA815_10676.1}
5. MligTC455_50343 155 3.22 Mlig455_047080

Neo: -

Age: -

0.955 - - - 0.955 - - Mlig455_047080 {REF} {Length: 6752} {Pfam: PDZ domain [PF00595.26, score=42.4]; PDZ domain [PF17820.3, score=37.6]; PDZ domain [PF13180.8, score=24.0]} {Smed: dd_Smed_v6_13914_0_1, dd_Smed_v6_13914_0_1, [Score=49.3, Expect=1e-05]} {RNA1509_8324} {RNA1310_1252.1} {RNA815_1215}
6. MligTC455_46722 205 4.28 Mlig455_028319

Neo: -

Age: -

CHRNA3 0.951 - - - 0.951 - - Mlig455_028319 {REF} {Length: 2247} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=276.5]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=220.5]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=421, Expect=1e-142]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=412, Expect=2e-138]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=408, Expect=2e-137]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=403, Expect=1e-135]} {Mouse: ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [RH, Score=407, Expect=4e-137]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=504, Expect=2e-175]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=432, Expect=5e-147]} {Smed: dd_Smed_v6_14630_0_1, dd_Smed_v6_14630_0_1, [Score=476, Expect=3e-163]} {RNA1509_55012} {RNA1310_6313.1} {RNA815_3014.1}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA